ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

AACR Changes Its Logo— For The Fifth Time Since 2000

July 11, 2014

Garb’s Questions, Answers About Cancer Program

December 5, 1980

Under Ultimatum, NIH Databases Remove “Misconduct” Tags From Papers By Fisher

February 24, 1995

In Brief: NSABP Selects 193 Institutions For STAR; ACR Names Evens, Ramsey As New Officers

October 9, 1998

Public Forum On NRSA Tuition Policies

April 14, 1995

Cullen To Leave NCI, Will Become Director Of AMC Cancer Center; Nixon May Join ACS

April 14, 1989